Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane
Status:
Terminated
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
Everolimus will be given to patients with metastatic breast cancer who already has a progress
taking Everolimus but with a change in the endocrine treatment.